XELJANZ / XELJANZ XR (tofacitinib) Contraindications

Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

XELJANZ/XELJANZ XR (tofacitinib) is contraindicated:

  • In patients with known hypersensitivity to tofacitinib or any of its components. For a complete listing, see DOSAGE FORMS, COMPOSITION AND PACKAGING section of the product monograph.
  • In patients with severe hepatic impairment.
  • During pregnancy and breastfeeding.